About
Regulatory Affairs, Quality Systems, CRO Services, and Commercial Support
Areas of Focus
Categories
Boston & New EnglandCg ClinicalCg DiagnosticsCg RegulatoryCg Strategy
Clinical Trials (16)
View allTotal Trials
16
As Lead Sponsor
12
As Collaborator
4
Total Enrollment
21,595
By Phase
NA: 4PHASE3: 1PHASE4: 5
By Status
COMPLETED: 9RECRUITING: 3TERMINATED: 2UNKNOWN: 1WITHDRAWN: 1
Clinical Trials Pipeline16 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
2051
2052
2053
2054
2055
2056
2057
2058
2059
2060
2061
2062
2063
2064
2065
2066
2067
2068
2069
2070
2071
2072
2073
2074
2075
2076
2077
2078
2079
2080
2081
2082
2083
2084
2085
2086
2087
2088
2089
2090
2091
2092
2093
2094
2095
2096
2097
2098
2099
2100
2101
Today
Hover over trial bars to see details
Recent Trials
NCT06844370Collaborator
Home Versus Hospital Based NIV Care in MND
NARecruiting
60 participants
Started: Mar 6, 2024 · Completed: Sep 30, 2026
NCT04695210Collaborator
Virtual Peer-to-peer Support Programme for Carers of MND
NARecruiting
154 participants
Started: Aug 15, 2022 · Completed: Jul 31, 2025
NCT03082287Collaborator
ALPCO Calprotectin ELISA - Measurement of Calprotectin Levels in Human Stool
N/ACompleted
424 participants
Started: May 1, 2017 · Completed: Oct 25, 2019
NCT01724671Lead Sponsor
Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline
N/AUnknown
30 participants
Started: Dec 31, 2012 · Completed: Dec 31, 2013
NCT01724229Lead Sponsor
Clinical Case Series Evaluating Skin Wellness System
NACompleted
20 participants
Started: Nov 30, 2012 · Completed: Jun 30, 2013
Locations (1)
Headquarters
Beverly, MA, United States
Map
Loading map...